Broadfin Capital’s Tandem Diabetes Care TNDM Stock Holding History

Broadfin Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-89,100	Closed	-$3.38M	–	47
2018 Q4	$3.38M	Sell	89,100 -483,979	-84%	-$17.1M	0.44%	41
2018 Q3	$24.6M	Buy	573,079 +2,481	+0.4%	+$86.6K	3.61%	8
2018 Q2	$12.6M	Buy	+570,598	New	+$7.02M	1.98%	19
2016 Q4	–	Sell	-33,430	Closed	-$2.56M	–	68
2016 Q3	$2.56M	Buy	+33,430	New	+$2.44M	0.23%	64
2015 Q2	–	Sell	-10,196	Closed	-$1.29M	–	97
2015 Q1	$1.29M	Buy	+10,196	New	+$1.33M	0.1%	79

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Broadfin Capital's TNDM Position: Q1 2019 in Review

Broadfin Capital sold out of Tandem Diabetes Care (TNDM) in Q1 2019, closing a stake of 89,100 shares — an estimated $3.38M sold.

Broadfin Capital first reported a position in TNDM in Q1 2015 and held it in 5 quarters. The position peaked at $24.6M in Q3 2018. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

Broadfin Capital reported no remaining Tandem Diabetes Care position as of Q1 2019 after selling out during the quarter.
Broadfin Capital sold 89,100 Tandem Diabetes Care shares in Q1 2019, an estimated $3.38M.
Broadfin Capital first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 5 quarters.
Broadfin Capital's Tandem Diabetes Care position peaked at $24.6M in Q3 2018.
265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Broadfin Capital's 13F filing for Q1 2019, filed 15 May 2019.